FDA recall Z-0947-2022

Product

Matrix Clinical Solution At-Home COVID-19 Test

Reason for recall

Due to COVID-19 Test not being authorized for home sample collection.

Distribution

U.S.: AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, and WV. O.U.S.: N/A

Key facts

Status

Ongoing

Initiation date

2022-01-24

Report date

2022-04-27

Voluntary/Mandated

Voluntary: Firm initiated

Location

Scottsdale, AZ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0947-2022